Cocrystal Pharma to Present at the April 2020 Virtual Investor Summit
April 15 2020 - 8:05AM
Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or
the “Company”), a clinical stage biotechnology company
discovering and developing novel antiviral therapeutics,
announced today that Dr. Gary Wilcox, Chairman and Chief Executive
Officer of Cocrystal will present at the April 2020 Virtual
Investor Summit on Wednesday, April 22nd, 2020 at 11:00 AM ET.
A live audio webcast of the presentation will be
available on the IR Calendar page of the Investors section of the
Company’s website (cocrystalpharma.com). Immediately following the
presentation, management will participate in an interactive Q&A
session with interested parties, allowing participants to type in
questions and receive live responses. A webcast replay will be
available two hours following the live presentation and will be
accessible for 30 days. To schedule a one-on-one call with
management, please contact the conference at
info@virtualinvestorsummit.com and for more information, please
visit virtualinvestorsummit.com. About Virtual Investor
Summit
The Virtual Investor Summit is an online
platform that offers both public and private companies, across
multiple industries the ability to stay active and engaged with the
investment community. Our inaugural summit on April 22-23, 2020
will feature company webcast presentations followed by a virtual,
interactive Q&A session, allowing participants to type in
questions and receive live responses. Interested participants also
have the ability to request one-on-one calls with a featured
company. For more information, please visit
virtualinvestorsummit.com.
About Cocrystal Pharma,
Inc.
Cocrystal Pharma, Inc. is a clinical stage
biotechnology company discovering and developing novel antiviral
therapeutics that target the replication process of influenza
viruses, hepatitis C viruses, noroviruses and coronaviruses.
Cocrystal employs unique structure-based technologies and Nobel
Prize winning expertise to create first- and best-in-class
antiviral drugs. For further information about Cocrystal, please
visit www.cocrystalpharma.com.
Investor and Media Contact:JTC
Team, LLC(833) 475-8247COCP@jtcir.com
Cocrystal Pharma (NASDAQ:COCP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cocrystal Pharma (NASDAQ:COCP)
Historical Stock Chart
From Apr 2023 to Apr 2024